Pharmacotherapy treatment of stimulant use disorder
Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment modality for SUDs and no pharmacotherapy is curr...
Saved in:
Main Author: | Mei T. Liu, PharmD, BCPP (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic treatment of bipolar disorder and comorbid adult attention-deficit/hyperactivity disorder
by: Anuja Vallabh, PharmD, BCPP
Published: (2024) -
Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021) -
Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021) -
Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population
by: Anupha M. Mathew, PharmD, BCPS, et al.
Published: (2023) -
Assessing the understandability, actionability, and quality of online resources for the self-management of bipolar disorder
by: Nathan D. Sutera, PharmD, et al.
Published: (2022)